Newsroom

Jun 05, 2024

Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T

View

May 23, 2024

Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting

View

Apr 11, 2024

Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT

View

Feb 23, 2024

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

View

Jan 03, 2024

Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

View

Dec 09, 2023

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

View

Nov 02, 2023

Orca Bio to Present Positive Clinical Data on its Novel High-Precision Cell Therapies at the 65th American Society of Hematology Annual Meeting

View

Feb 16, 2023

Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

View